{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:55:29Z","timestamp":1791356129213,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.diabet.2008.09.007","type":"journal-article","created":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T04:39:09Z","timestamp":1235882349000},"page":"77-84","source":"Crossref","is-referenced-by-count":87,"title":["Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention"],"prefix":"10.1016","volume":"35","author":[{"given":"M.","family":"Karaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Magnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2008.09.007_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type2 diabetes\u00a0\u2013\u00a0a matter of beta-cell life and death?","volume":"307","author":"Rhodes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.diabet.2008.09.007_bib2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2337\/diabetes.50.2007.S30","article-title":"Endocrine pancreas plasticity under physiological and pathological conditions","volume":"50","author":"Bernard-Kargar","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1210\/en.130.3.1459","article-title":"Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion","volume":"130","author":"Parson","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2008.09.007_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/acta.0.0750087","article-title":"Insulin response to glucose infusion during pregnancy. A prospective study of high- and low-insulin responders with normal carbohydrate tolerance","volume":"75","author":"Edstr\u00f6m","year":"1974","journal-title":"Acta Endocr (Kbh)"},{"key":"10.1016\/j.diabet.2008.09.007_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/JME-06-0053","article-title":"Molecular regulation of pancreatic beta-cell mass development, maintenance and expansion","volume":"38","author":"Ackermann","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.diabet.2008.09.007_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/diabetes.44.8.863","article-title":"Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications","volume":"44","author":"Unger","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/diabetes.47.7.1058","article-title":"Pancreatic beta-cell regeneration after 48-hour glucose infusion in mildly diabetic rats is not correlated with functional improvement","volume":"47","author":"Bernard","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3181\/00379727-173-41611","article-title":"The diabetic Zucker fatty rat","volume":"173","author":"Clark","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.diabet.2008.09.007_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/diabetes.47.3.358","article-title":"Role of apoptosis in failure of beta-cell mass compensation for insulinresistance and beta-cell defects in the male Zucker diabetic fatty rat","volume":"47","author":"Pick","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.270.3.1295","article-title":"Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic and metabolic abnormalities by increased long chain fatty acids","volume":"270","author":"Milburn","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabet.2008.09.007_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0026-0495(99)90219-6","article-title":"Basal insulin hypersecretion in insulinresistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism","volume":"48","author":"Zhou","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2008.09.007_bib12","series-title":"Frontiers in Diabetes Research. Lessons from Animal Diabetes","first-page":"225","article-title":"The Zucker diabetic fatty (ZDF) rat","author":"Peterson","year":"1995"},{"key":"10.1016\/j.diabet.2008.09.007_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0026-0495(00)80049-9","article-title":"Profiling of Zucker diabetic fatty rats in their progression to overt diabetic state","volume":"49","author":"Etgen","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2008.09.007_bib14","doi-asserted-by":"crossref","first-page":"E1730","DOI":"10.1152\/ajpendo.00572.2007","article-title":"The dynamics of insulin sensitivity, beta cell function and beta cell mass during the development of diabetes in fa\/fa rats","volume":"293","author":"Topp","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabet.2008.09.007_bib15","series-title":"Frontiers in Diabetes Research. Lessons from Animal DiabetesIII","first-page":"212","article-title":"Achieving predictable model of type2 diabetes in the sand rat","author":"Adlerr","year":"1991"},{"key":"10.1016\/j.diabet.2008.09.007_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/JBCPP.1993.4.1-2.83","article-title":"Psammomys obesus of the Jerusalem colony: a model for nutritionally induced non-insulindependent diabetes","volume":"4","author":"Shafrir","year":"1993","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.diabet.2008.09.007_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/diabetes.54.1.138","article-title":"Dynamic changes in beta-cell mass and pancreatic insulin during evolution of nutrition-dependent diabetes in Psammomys obesus","volume":"54","author":"Kaiser","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diabetes.54.suppl_2.S137","article-title":"Psammomys obesus, a model for environment-gene interactions in type2 diabetes","volume":"54","author":"Kaiser","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.arcmed.2005.01.003","article-title":"Pathogenesis of type2 diabetes mellitus","volume":"36","author":"Leahy","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.diabet.2008.09.007_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib21","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2002-020735","article-title":"Selective beta-cell loss and alpha-cell expansion in patients with type2 diabetes mellitus in Korea","volume":"88","author":"Yoon","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2008.09.007_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","article-title":"Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients","volume":"45","author":"Sakuraba","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2008.09.007_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/diabetes.53.3.624","article-title":"Structural and functional abnormalities in the islets isolated from type2 diabetic subjects","volume":"53","author":"Deng","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/1043-2760(94)90003-5","article-title":"Islet cell growth and the growth factors involved","volume":"5","author":"Bonner-Weir","year":"1994","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabet.2008.09.007_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.44.3.249","article-title":"Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical method","volume":"44","author":"Finegood","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diabetes.50.2007.S20","article-title":"Beta-cell turnover. Its assessment and implications","volume":"50","author":"Bonner-Weir","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib27","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1210\/en.138.4.1736","article-title":"Apoptosis participates in the remodelling of the endocrine pancreas in the neonatal rat","volume":"138","author":"Scaglia","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2008.09.007_bib28","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1210\/en.141.6.1926","article-title":"Perspective: postnatal pancreatic beta-cell growth","volume":"141","author":"Bonner-Weir","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2008.09.007_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1471-4914(02)02377-8","article-title":"Pancreatic beta-cell growth and survival-a role in obesity-linked type2 diabetes?","volume":"8","author":"Lingohr","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.diabet.2008.09.007_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature02520","article-title":"Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation","volume":"429","author":"Dor","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2008.09.007_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/er.2007-0023","article-title":"Glucolipotoxicity: fuel excess and beta-cell dysfunction","author":"Poitout","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabet.2008.09.007_bib32","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.2337\/diabetes.51.2007.S405","article-title":"Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the aetiology of diabetes","volume":"51","author":"Prentki","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/diabetes.52.3.581","article-title":"Glucose toxicity in beta cells: type2 diabetes, good radicals gone bad and the glutathione connection","volume":"52","author":"Robertson","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib34","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"Robertson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabet.2008.09.007_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/diabetes.45.3.273","article-title":"Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?","volume":"45","author":"Prentki","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2008.09.007_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/en.143.2.339","article-title":"Minireview: secondary beta-cell failure in type2 diabetes\u00a0\u2013\u00a0a convergence of glucotoxicity and lipotoxicity","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2008.09.007_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cmet.2006.07.007","article-title":"Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1","volume":"4","author":"Lipson","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabet.2008.09.007_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156652406775574613","article-title":"Endoplasmic reticulum stress-induced apoptosis and auto-immunity in diabetes","volume":"6","author":"Lipson","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.diabet.2008.09.007_bib39","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1089\/ars.2007.1790","article-title":"Endoplasmic reticulum stress signaling in pancreatic beta cells","volume":"9","author":"Fonseca","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.diabet.2008.09.007_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.regpep.2004.07.019","article-title":"GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice","volume":"128","author":"Hansotia","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.diabet.2008.09.007_bib41","doi-asserted-by":"crossref","first-page":"19601","DOI":"10.1073\/pnas.0704796104","article-title":"Beta-cell specific deficiency of the stimulatory G-protein alpha-subunit Gs-alpha leads to reduced beta cell mass and insulin-deficient diabetes","volume":"104","author":"Xie","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diabet.2008.09.007_bib42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00125-004-1379-6","article-title":"Glucagon-like peptide-1 prevents beta-cell glucolipotoxicity","volume":"47","author":"Buteau","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2008.09.007_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/10.1210\/er.2006-0038","article-title":"Beta-cell failure in diabetes and preservation by clinical treatment","volume":"28","author":"Wajchenberg","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabet.2008.09.007_bib44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.diabet.2008.09.007_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.med.57.110104.115624","article-title":"Therapeutic approaches to preserve islet mass in type2 diabetes","volume":"57","author":"Baggio","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.diabet.2008.09.007_bib46","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type2 diabetes: a parallel-group study","volume":"359","author":"Zander","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2008.09.007_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul Pept"},{"key":"10.1016\/j.diabet.2008.09.007_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1359-6446(05)03460-4","article-title":"Incretin mimetics and DPP-IV inhibitors for the treatment of type2 diabetes","volume":"10","author":"Nielsen","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.diabet.2008.09.007_bib49","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc06-2375","article-title":"Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type2 diabetes","volume":"30","author":"Kim","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2008.09.007_bib50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1464-5491.2007.02333.x","article-title":"Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic beta-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with type2 diabetes mellitus","volume":"25","author":"Vilsb\u00f8ll","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2008.09.007_bib51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type2 diabetes","volume":"298","author":"Amori","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2008.09.007_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase-IV from bench to bedside: an update on structural properties, functions and clinical aspects of the enzyme DPP-IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363609000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363609000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T06:14:11Z","timestamp":1558160051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363609000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1262363609000111"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2008.09.007","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}